Own experience of "Glicifon" using as a local chemotherapy drug for the patients with basal-cell head&neck carcinoma
Introduction. Skin cancer is the most common type among the cancer statistics. It accounts up to 14.2 % of all types of cancer. Basal cell cancer (BCC) is the most common among the skin cancers. Despite the possibilities of using different types of treatment BCC the long-term results are infavorable...
Saved in:
| Main Author: | D. N. Reshetov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-04-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/620 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of Kuraderm drug in the treatment of basal cell carcinoma of the head and neck
by: V. Z. Dobrokhotova, et al.
Published: (2016-10-01) -
Comparative Study of CO₂ Laser and Curettage-Electrodesiccation for Superficial Basal Cell Carcinoma Treatment: A Focus on Cosmetic Results
by: Pelle Kahr Nilsson, et al.
Published: (2025-07-01) -
Experience in local Glyciphon chemotherapy of basal cell carcinoma of the problem face areas
by: S. O. Podvyaznikov
Published: (2017-04-01) -
Accuracy of Dermatoscopy in the Diagnosis of Basal Cell Carcinoma on the Skin of Head and Neck
by: Dindar Sharif Qurt, et al.
Published: (2023-05-01) -
Basal cell carcinoma in the scrotal region of a young male patient: atypical presentation
by: Lucas S. Madureira, et al.
Published: (2025-01-01)